Breaking News
Sort by:
Top Post
Orbia's Koura Business Opens World's First HFA 152a Medical Propellant Production Facility
Koura, a global leader in the development, manufacture, and supply of fluoroproducts and technologies,[2] today opens […]
Researchers Discover New Model for "Global" DNA Repair
Two studies provide a radically new picture of how bacterial cells continually repair damaged sections […]
Neuron23 Closes $100 Million Series C Financing Round, Nominates Clinical Candidate for Parkinson's Disease
Neuron23™ Inc., an early stage biotechnology company focused on developing precision medicines for genetically defined […]
NHS Comment On Study Linking Type 2 Diabetes To Earlier Health Problems
Comment from Professor Jonathan Valabhji on a new study from the University of Cambridge, that […]
Owkin Announces New Scientific Advisory Board Chaired by World-leading Precision Oncologist
French-American AI for medical research startup Owkin today appointed ten advisors to its Scientific Advisory […]
NHS Announces £127m Maternity Boost for Patients and Families
The NHS in England has today announced a £127 million funding boost for maternity services across […]
TendoNova wins FDA Clearance for Its New Microinvasive Ocelot Surgical Tool
TendoNova, an emerging leader in microinvasive sports medicine procedures, is pleased to announce the FDA […]
CELLTREAT Acquires VistaLab Technologies
CELLTREAT® Scientific Products (“CELLTREAT”) and VistaLab™ Technologies (“VistaLab”) today announced the execution of a definitive agreement under […]
Seabelife Receives Close to €1.4m Deep Tech Financing from Bpifrance
SeaBeLife, a biotech company developing drug candidates intended to block cell necrosis, today announces that […]
Index Pharmaceuticals Prepares for Commercialisation of Cobitolimod
InDex Pharmaceuticals Holding AB (publ)is planning for self-commercialisation of the drug candidate cobitolimod in the […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more